Home Cart 0 Sign in  
X

[ CAS No. 62019-56-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 62019-56-1
Chemical Structure| 62019-56-1
Chemical Structure| 62019-56-1
Structure of 62019-56-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 62019-56-1 ]

Related Doc. of [ 62019-56-1 ]

Alternatived Products of [ 62019-56-1 ]

Product Details of [ 62019-56-1 ]

CAS No. :62019-56-1 MDL No. :MFCD09909676
Formula : C4HCl2NO2S Boiling Point : -
Linear Structure Formula :- InChI Key :AMEPJXXVIJZMJL-UHFFFAOYSA-N
M.W : 198.03 Pubchem ID :12333169
Synonyms :

Calculated chemistry of [ 62019-56-1 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 39.09
TPSA : 78.43 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.56 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.35
Log Po/w (XLOGP3) : 2.74
Log Po/w (WLOGP) : 2.15
Log Po/w (MLOGP) : 0.55
Log Po/w (SILICOS-IT) : 2.92
Consensus Log Po/w : 1.94

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.1
Solubility : 0.158 mg/ml ; 0.000798 mol/l
Class : Soluble
Log S (Ali) : -4.04
Solubility : 0.018 mg/ml ; 0.0000909 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -1.91
Solubility : 2.46 mg/ml ; 0.0124 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.8

Safety of [ 62019-56-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 62019-56-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 62019-56-1 ]
  • Downstream synthetic route of [ 62019-56-1 ]

[ 62019-56-1 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 92972-48-0 ]
  • [ 62019-56-1 ]
YieldReaction ConditionsOperation in experiment
88% With sodium chlorite; aminosulfonic acid; water In tetrahydrofuran at 20℃; for 2 h; To a solution of compound II (500 mg, 2.74 mmol) in THF (18 ml) and water (12 ml) was added a mixture of sulfanylamide (346 mg, 3.56 mmol) and NaClO2 (323 mg, 3.56 mmol) in water (2 ml). The mixture was stirred at room temperature for 2 hours, diluted with AcOEt, and washed with water. The organic phase was separated, concentrated in vacuo to afford the title compound of formula III (440 mg, 88percent) as a yellow solid.
Reference: [1] Patent: US2009/270456, 2009, A1, . Location in patent: Page/Page column 8
  • 2
  • [ 124-38-9 ]
  • [ 4175-76-2 ]
  • [ 62019-56-1 ]
YieldReaction ConditionsOperation in experiment
48 g With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -78 - 20℃; for 18 h; Cooling Diisopropylamine (42 ml, 297 mmol) was dissolved in 1000 ml THF and cooled to -70°C. 181 .2 ml nBuLi (1.6M in hexane, 290 mmol) was added. The temperature was briefly raised to 0°C and the reaction mixture was again cooled down to -70°C. 2,4-Dichlorothiazole (40.8 g, 265 mmol) in 200 ml THF was slowly added at -70°C. Dry ice was put in a separate vessel connected to the reaction mixture with a teflon tube and the C02 formed bubbled in the reaction mixture at -78°C. The mixture was stirred for 18 hours in the cooling bath and the temperature reached 20°C. The mixture was quenched with 2N HCI. After saturating the water phase with NaCI, the mixture was extracted with ethyl acetate, dried with MgS04 and evaporated to give 48.0 g 2,4-dichloro-thiazole-5-carboxylic acid, Mp: 165 - 166°C.
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992, # 2, p. 215 - 219
[2] Patent: EP2532661, 2012, A1, . Location in patent: Page/Page column 23-24
[3] Patent: WO2012/168361, 2012, A1, . Location in patent: Page/Page column 49-50
[4] Patent: WO2013/156433, 2013, A1, . Location in patent: Page/Page column 19; 37-38
[5] Patent: WO2017/156493, 2017, A1, . Location in patent: Paragraph 0182; 0214
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 62019-56-1 ]

Chlorides

Chemical Structure| 170232-69-6

[ 170232-69-6 ]

(2,4-Dichlorothiazol-5-yl)methanol

Similarity: 0.85

Chemical Structure| 1015591-57-7

[ 1015591-57-7 ]

Methyl 4-chlorothiazole-5-carboxylate

Similarity: 0.85

Chemical Structure| 72605-86-8

[ 72605-86-8 ]

Methyl 2-chlorothiazole-5-carboxylate

Similarity: 0.79

Chemical Structure| 81449-93-6

[ 81449-93-6 ]

Ethyl 2-chlorothiazole-5-carboxylate

Similarity: 0.78

Chemical Structure| 104146-17-0

[ 104146-17-0 ]

4-Chlorothiazole-5-carbaldehyde

Similarity: 0.73

Carboxylic Acids

Chemical Structure| 14527-41-4

[ 14527-41-4 ]

5-Thiazolecarboxylic acid

Similarity: 0.68

Chemical Structure| 40283-46-3

[ 40283-46-3 ]

2-Aminothiazole-5-carboxylic acid

Similarity: 0.63

Chemical Structure| 40004-69-1

[ 40004-69-1 ]

2-Methyl-5-thiazolecarboxylic acid

Similarity: 0.62

Chemical Structure| 20485-41-0

[ 20485-41-0 ]

4-Methylthiazole-5-carboxylic acid

Similarity: 0.60

Chemical Structure| 54045-76-0

[ 54045-76-0 ]

2-Bromothiazole-5-carboxylic acid

Similarity: 0.59

Related Parent Nucleus of
[ 62019-56-1 ]

Thiazoles

Chemical Structure| 170232-69-6

[ 170232-69-6 ]

(2,4-Dichlorothiazol-5-yl)methanol

Similarity: 0.85

Chemical Structure| 1015591-57-7

[ 1015591-57-7 ]

Methyl 4-chlorothiazole-5-carboxylate

Similarity: 0.85

Chemical Structure| 72605-86-8

[ 72605-86-8 ]

Methyl 2-chlorothiazole-5-carboxylate

Similarity: 0.79

Chemical Structure| 81449-93-6

[ 81449-93-6 ]

Ethyl 2-chlorothiazole-5-carboxylate

Similarity: 0.78

Chemical Structure| 104146-17-0

[ 104146-17-0 ]

4-Chlorothiazole-5-carbaldehyde

Similarity: 0.73